JP2002514084A5 - - Google Patents

Download PDF

Info

Publication number
JP2002514084A5
JP2002514084A5 JP1998550634A JP55063498A JP2002514084A5 JP 2002514084 A5 JP2002514084 A5 JP 2002514084A5 JP 1998550634 A JP1998550634 A JP 1998550634A JP 55063498 A JP55063498 A JP 55063498A JP 2002514084 A5 JP2002514084 A5 JP 2002514084A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998550634A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002514084A (ja
JP4162155B2 (ja
Filing date
Publication date
Priority claimed from US09/073,010 external-priority patent/US6613881B1/en
Application filed filed Critical
Publication of JP2002514084A publication Critical patent/JP2002514084A/ja
Publication of JP2002514084A5 publication Critical patent/JP2002514084A5/ja
Application granted granted Critical
Publication of JP4162155B2 publication Critical patent/JP4162155B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP55063498A 1997-05-20 1998-05-20 結核の免疫治療および診断のための化合物およびそれらの使用方法 Expired - Fee Related JP4162155B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US85938197A 1997-05-20 1997-05-20
US08/859,381 1997-05-20
US09/073,010 US6613881B1 (en) 1997-05-20 1998-05-05 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
US09/073,010 1998-05-05
PCT/US1998/010407 WO1998053075A2 (en) 1997-05-20 1998-05-20 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use

Related Child Applications (3)

Application Number Title Priority Date Filing Date
JP2008070066A Division JP4764445B2 (ja) 1997-05-20 2008-03-18 結核の免疫治療および診断のための化合物およびそれらの使用方法
JP2008070069A Division JP4759010B2 (ja) 1997-05-20 2008-03-18 結核の免疫治療および診断のための化合物およびそれらの使用方法
JP2008070073A Division JP4759011B2 (ja) 1997-05-20 2008-03-18 結核の免疫治療および診断のための化合物およびそれらの使用方法

Publications (3)

Publication Number Publication Date
JP2002514084A JP2002514084A (ja) 2002-05-14
JP2002514084A5 true JP2002514084A5 (enExample) 2005-12-08
JP4162155B2 JP4162155B2 (ja) 2008-10-08

Family

ID=26754016

Family Applications (4)

Application Number Title Priority Date Filing Date
JP55063498A Expired - Fee Related JP4162155B2 (ja) 1997-05-20 1998-05-20 結核の免疫治療および診断のための化合物およびそれらの使用方法
JP2008070069A Expired - Fee Related JP4759010B2 (ja) 1997-05-20 2008-03-18 結核の免疫治療および診断のための化合物およびそれらの使用方法
JP2008070073A Expired - Fee Related JP4759011B2 (ja) 1997-05-20 2008-03-18 結核の免疫治療および診断のための化合物およびそれらの使用方法
JP2008070066A Expired - Fee Related JP4764445B2 (ja) 1997-05-20 2008-03-18 結核の免疫治療および診断のための化合物およびそれらの使用方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2008070069A Expired - Fee Related JP4759010B2 (ja) 1997-05-20 2008-03-18 結核の免疫治療および診断のための化合物およびそれらの使用方法
JP2008070073A Expired - Fee Related JP4759011B2 (ja) 1997-05-20 2008-03-18 結核の免疫治療および診断のための化合物およびそれらの使用方法
JP2008070066A Expired - Fee Related JP4764445B2 (ja) 1997-05-20 2008-03-18 結核の免疫治療および診断のための化合物およびそれらの使用方法

Country Status (20)

Country Link
US (1) US6613881B1 (enExample)
EP (4) EP1012293B1 (enExample)
JP (4) JP4162155B2 (enExample)
KR (4) KR100652513B1 (enExample)
AT (1) ATE420180T1 (enExample)
AU (1) AU742751B2 (enExample)
BR (1) BR9809445A (enExample)
CA (2) CA2290774A1 (enExample)
CZ (2) CZ303194B6 (enExample)
DE (1) DE69840449D1 (enExample)
DK (1) DK1012293T3 (enExample)
ES (1) ES2321039T3 (enExample)
HU (1) HU226520B1 (enExample)
IL (2) IL133056A0 (enExample)
NO (4) NO324880B1 (enExample)
NZ (1) NZ501310A (enExample)
PL (1) PL191121B1 (enExample)
PT (1) PT1012293E (enExample)
TR (1) TR200000115T2 (enExample)
WO (1) WO1998053075A2 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6592877B1 (en) * 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
EP2085090A3 (en) * 1997-06-06 2012-05-02 The Regents of the University of California Inhibitors of DNA immunostimulatory sequence activity
CA2319380A1 (en) * 1997-11-10 1999-05-20 Statens Serum Institut Nucleic acid fragments and polypeptide fragments derived from m. tuberculosis
DK1144447T3 (da) * 1998-11-04 2010-02-08 Isis Innovation Dianostisk tuberkulosetest
US7083796B2 (en) * 2000-06-20 2006-08-01 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
US20030027774A1 (en) * 1999-03-18 2003-02-06 Ronald C. Hendrickson Tuberculosis antigens and methods of use therefor
US8143386B2 (en) * 1999-04-07 2012-03-27 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
AU779495B2 (en) * 1999-07-13 2005-01-27 Statens Serum Institut Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosis esat-6 gene family
AU779978B2 (en) 1999-10-07 2005-02-24 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
WO2001062893A2 (en) * 2000-02-25 2001-08-30 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
CA2405247A1 (en) * 2000-04-19 2001-10-25 Statens Serum Institut Tuberculosis antigens and methods of use thereof
AU2003213118A1 (en) * 2002-02-15 2003-09-09 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
US7482116B2 (en) 2002-06-07 2009-01-27 Dna Genotek Inc. Compositions and methods for obtaining nucleic acids from sputum
US20050164168A1 (en) * 2003-03-28 2005-07-28 Cullum Malford E. Method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
US8475735B2 (en) * 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
EP1812580B1 (en) 2004-11-16 2014-12-17 Crucell Holland B.V. Multivalent vaccines comprising recombinant viral vectors
WO2006117538A2 (en) * 2005-04-29 2006-11-09 Fusion Antibodies Limited Assays for diagnosis of tuberculosis and uses thereof
WO2007005627A2 (en) 2005-07-01 2007-01-11 Forsyth Dental Infirmary For Children Tuberculosis antigen detection assays and vaccines
WO2007041539A1 (en) * 2005-09-30 2007-04-12 Transcutaneous Technologies, Inc. Iontophoresis apparatus and method for the diagnosis of tuberculosis
EP2441493B1 (en) 2006-03-14 2014-05-07 Oregon Health and Science University Methods for producing an immune response to tuberculosis
EP2315597B1 (en) 2008-07-25 2017-08-23 GlaxoSmithKline Biologicals S.A. Novel compositions and methods
PL2315834T3 (pl) 2008-07-25 2018-12-31 Glaxosmithkline Biologicals S.A. Białko rv2386c związane z gruźlicą, jego kompozycje i zastosowania
LT2315773T (lt) * 2008-07-25 2016-11-10 Glaxosmithkline Biologicals S.A. Polipeptidai, polinukleotidai ir kompozicijos, skirti naudoti latentinės tuberkuliozės gydymui
CN102869372B (zh) 2010-01-27 2016-01-20 葛兰素史密丝克莱恩生物有限公司 经修饰的结核抗原
GB201012072D0 (en) * 2010-07-19 2010-09-01 Sec Dep For Environment Food A Diagnostic reagents
IN2014MN00032A (enExample) 2011-06-19 2015-06-12 Abogen Inc
US12038434B2 (en) * 2015-02-09 2024-07-16 DNA Genotek, Inc. Devices, solutions and methods for sample collection related applications, analysis and diagnosis

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4689397A (en) 1985-08-12 1987-08-25 Scripps Clinic And Research Foundation Synthetic polypeptides for detecting mycobacterial infections
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US4879213A (en) 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
US4976958A (en) * 1987-02-26 1990-12-11 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US4952395A (en) 1987-02-26 1990-08-28 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
US5330754A (en) 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
CA2179772A1 (en) * 1993-12-23 1995-06-29 William R. Jacobs Mycobacteria virulence factors and a method for their identification
IE960132A1 (en) * 1995-03-13 1996-09-18 Astra Ab New DNA molecules
CN1154730C (zh) 1995-09-01 2004-06-23 科里克萨有限公司 用于结核病诊断的化合物和方法
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
NZ319377A (en) 1995-09-01 2000-01-28 Corixa Corp polypeptides comprising a portion of a soluble M tuberculosis antigen
AU4750597A (en) * 1996-10-11 1998-05-11 Corixa Corporation Compounds and methods for diagnosis of tuberculosis

Similar Documents

Publication Publication Date Title
JP2000509942A5 (enExample)
JP2000509637A5 (enExample)
JP2000507042A5 (enExample)
JP2000509635A5 (enExample)
JP2000509912A5 (enExample)
JP2000510751A5 (enExample)
JP2000509587A5 (enExample)
JP2000507369A5 (enExample)
JP2000507433A5 (enExample)
JP2000508866A5 (enExample)
JP2000510793A5 (enExample)
JP2000508022A5 (enExample)
JP2000508841A5 (enExample)
JP2002514084A5 (enExample)
JP2000508680A5 (enExample)
JP2000509804A5 (enExample)
JP2000509853A5 (enExample)
JP2000509755A5 (enExample)
JP2000510247A5 (enExample)
JP2000510969A5 (enExample)
JP2000508836A5 (enExample)
JP2000508102A5 (enExample)
JP2000509818A5 (enExample)
JP2000509520A5 (enExample)
JP2000507434A5 (enExample)